slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
16,98 CNY | -1,28% | +0,24% | -5,14% |
Vakgebied
Aantal werknemers: 444
Verkoop per activiteit
CNY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Arachidonic Acid
73,1
%
| 256 | 66,2 % | 302 | 73,1 % | +18,22% |
Docosahexaenoic Acid
19,2
%
| 65 | 16,7 % | 79 | 19,2 % | +23,09% |
Sialic Acid
5,6
%
| 34 | 8,9 % | 23 | 5,6 % | -32,60% |
Other Business
2,0
%
| 31 | 8,1 % | 8 | 2,0 % | -73,16% |
Verkoop per regio
CNY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
China
62,3
%
| 231 | 57,6 % | 271 | 62,3 % | +17,17% |
Overseas
37,7
%
| 171 | 42,4 % | 164 | 37,7 % | -3,77% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
De Wei Yi
CEO | Chief Executive Officer | 59 | 22-09-04 |
Hua Biao Wang
DFI | Director of Finance/CFO | 59 | 22-09-04 |
Zhi Ming Wang
CTO | Chief Tech/Sci/R&D Officer | 55 | 22-09-04 |
Bin Du
BRD | Director/Board Member | 59 | 22-09-04 |
Fang Wang
IRC | Investor Relations Contact | 34 | 01-06-20 |
Xiang Yu Li
PRN | Corporate Officer/Principal | 46 | 27-12-21 |
Hua Rong Yi
SEC | Corporate Secretary | 48 | 29-03-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Yi fei Wang
BRD | Director/Board Member | 43 | 27-12-21 |
De Wei Yi
CEO | Chief Executive Officer | 59 | 22-09-04 |
Qi Liu
BRD | Director/Board Member | 47 | 27-12-21 |
Bin Du
BRD | Director/Board Member | 59 | 22-09-04 |
Hua Biao Wang
DFI | Director of Finance/CFO | 59 | 22-09-04 |
Yu Jun Wu
BRD | Director/Board Member | 39 | 01-04-15 |
Zhi Ming Wang
CTO | Chief Tech/Sci/R&D Officer | 55 | 22-09-04 |
Xiang Dong Chen
BRD | Director/Board Member | 61 | 27-12-21 |
Chun Li
BRD | Director/Board Member | 54 | 27-12-21 |
Jing Chen
BRD | Director/Board Member | 41 | 27-12-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 168 309 120 | 84 114 414 ( 49,98 %) | 0 | 49,98 % |
Bedrijfsgegevens
Cabio Biotech (Wuhan) Co., Ltd.
999 Gaoxin Avenue East Lake New Technology Dev Zone
430075, Wuhan
+
http://www.cabio.cnSector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-5,14% | 395 mln. | |
+17,57% | 8,47 mld. | |
+3,37% | 7,6 mld. | |
+5,65% | 6,26 mld. | |
-4,57% | 3,78 mld. | |
-6,87% | 3,73 mld. | |
-2,14% | 1,35 mld. | |
-26,41% | 1,12 mld. | |
+15,61% | 998 mln. | |
-7,15% | 948 mln. |
- Beurs
- Aandelen
- Koers 688089
- Onderneming Cabio Biotech (Wuhan) Co., Ltd.